OCUGEN INC. - COMMON STOCK
0.5761
12-March-25 14:57:40
15 minutes delayed
Stocks
+0.0295
+5.40%
Today's range
0.5621 - 0.5845
ISIN
N/A
Source
NASDAQ
-
Ocugen, Inc. Announces Positive DSMB Recommendation for OCU400-101 Clinical Trial
25 Apr 2022 07:33:00 By Nasdaq GlobeNewswire
-
Ocugen, Inc. to Present at NobleCon18
19 Apr 2022 17:32:00 By Nasdaq GlobeNewswire
-
Ocugen, Inc. to Commercialize COVAXIN™ in Mexico, Rights Now Encompassing All of North America
18 Apr 2022 07:11:00 By Nasdaq GlobeNewswire
-
Ocugen, Inc. Provides Update on its Phase 2/3 Study of COVAXIN™ (BBV152)
12 Apr 2022 08:31:00 By Nasdaq GlobeNewswire
-
01 Apr 2022 07:37:00 By Nasdaq GlobeNewswire
-
Ocugen Announces Appointment of Marna C. Whittington, PhD, to Board of Directors
23 Mar 2022 07:44:00 By Nasdaq GlobeNewswire
-
21 Mar 2022 18:36:00 By Nasdaq GlobeNewswire
-
Ocugen Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18 Mar 2022 17:56:00 By Nasdaq GlobeNewswire
-
Ocugen, Inc. to Present at the 34th Annual ROTH Conference
09 Mar 2022 07:11:00 By Nasdaq GlobeNewswire
-
Ocugen Provides an Update on its COVAXIN™ Pediatric (2-18) Emergency Use Authorization (EUA) Request
04 Mar 2022 07:01:00 By Nasdaq GlobeNewswire